The global compound pharmacy packaging market is growing rapidly and is expected to see a significant increase in revenue from 2025 to 2034. Key players in the market are focusing on mergers and acquisitions to develop advanced technologies for manufacturing compound pharmacy packaging, which will drive the markets growth during this period.
Global Compound Pharmacy Packaging Market Players
Latest Announcements by Compound Pharmacy Packaging Industry Leaders
Chief Commercial Marketing & Innovation Officer Carole Grassi Mircich claims that SGD Pharma has a track record of promptly meeting its clients changing pharmaceutical packaging requirements. The expansion of Sterinity range coincides with a boom in the demand for parenteral medications worldwide. For biologics and novel treatments that call for glass vials for parenteral administration, companies handy new 10ml and 20ml ISO molded glass vials in tray offer the best packaging option. SGD Pharma will be at the forefront of the worldwide business by innovating and producing superior primary glass packaging for companies clients and partners.
New Advancements in Compound Pharmacy Packaging Industry
- In May 2025, Aptar CSP Technologies, part of AptarGroup, revealed the expansion of its service range with the introduction of a cGMP-compliant manufacturing facility in New Jersey. Using Aptar CSPs own Activ-Polymer platform and Activ-Blister solutions, the new website will facilitate clinical packaging for oral solid dose (OSD) and capsule-based DPI medications. The expansion responds to the markets increasing need for improved medication stability and risk reduction from nitrosamines. By incorporating a highly-engineered active film material into thermoform and cold-form blister packaging configurations, Aptar CSP Activ-Blister technology creates a microclimate that shields individual doses from oxygen, moisture, volatile organic compounds, and degradation, including lowering the possibility of N-nitrosamine formation.
- In January 2025, Cascade Specialty Pharmacy, located in Washington, was acquired by Revelation Pharma, a prominent nationwide network of 503A and 503B compounding pharmacies, today. Revelation Pharmas expanding portfolio benefits from Cascade Specialty Pharmacys strong tradition of competence in ENT and animal health compounding.
Become a valued research partner with us, please feel free to contact us at sales@towardspackaging.com
